During in-vitro fertilization (IVF), a drug inhibits granulosa cell aromatase activity within ovarian follicles. Which outcome is most likely?

💡 Explanation

Aromatase converts androgens to estrogens within ovarian follicles. Inhibiting aromatase reduces estradiol synthesis because the aromatization mechanism is blocked, therefore intrafollicular estradiol decreases, rather than other hormonal changes that would normally result from estradiol stimulation.

• Why does skin blood flow increase when core body temperature rises above the hypothalamic set point during exercise?
• What causes the eventual decompensation of blood pressure observed during progressive hypovolemic shock in trauma patients?
• A patient with a deiodinase enzyme defect has high T4 levels, yet exhibits hypothyroid symptoms. Why does this condition cause a seemingly paradoxical presentation?
• Why does tanning via melanogenesis offer limited protection against UVB-induced DNA damage, even as skin darkens?
• A patient with severe peripheral artery disease experiences increased blood viscosity in the lower limbs. Which mechanism explains why this increased viscosity diminishes the effectiveness of vasodilators?
• An elderly patient with chronic hypertension experiences increased arterial stiffness, reducing baroreceptor sensitivity. What happens to aldosterone secretion due to these changes?